High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes

Cell-based high-content screening (HCS) assays have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. The time- and cost-effectiveness of HCS assays, combined with the organotypic nature o...

Full description

Saved in:
Bibliographic Details
Published in:Assay Drug Dev Technol
Main Authors: Grimm, Fabian Alexander, Iwata, Yasuhiro, Sirenko, Oksana, Bittner, Michael, Rusyn, Ivan
Format: Artigo
Language:Inglês
Published: Mary Ann Liebert, Inc. 2015
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4652224/
https://ncbi.nlm.nih.gov/pubmed/26539751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/adt.2015.659
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items